New study has potential to cure/slow cancer

Roswell Park conducts unique clinical trial
Posted at 5:44 PM, Nov 02, 2017
and last updated 2017-11-02 17:44:55-04

It could be a shot in the arm for cancer treatment. 

According to researchers at Roswell Park Cancer Institute, they are in the process of a new clinical trial that could one day cure certain cancers. 

The trial takes T-cells from a cancer patient, and boosts them to make super T-cells. “We introduce new genes into the T-cells in order for them to target the tumors specifically in a more efficient way,” said lead scientific researcher, Dr. Richard Koya. Those super cells are then injected back into the patient's arm to attack the cancer.

So far, they're finding reactions vary. But, Koya believes the T-cells can treat any cancers with solid tumors. “In theory it can target any kind of cancer,” Koya said.

Koya said the idea brings hope to those involved in the trial where chemotherapy and radiation have failed them. “Those are patients that are very sick and need our help.”

Immunotherapy continues to be a focal point for cancer researchers across the globe. But reps at Roswell said this one is unique based on the strength of their T-cells. “This is the first time this kind of study is taking place anywhere in the world,” said Roswell Park Cancer Institute Deputy Director, Dr. Kunle Odunsi. 

“We expect if not cure prolong remission of these cancers,” Koya said.

The trial is expected to last two years and is still accepting new patients. For more information on this research or other clinical trials available at Roswell Park, please call 1-877-ASK-RPCI(1-877-275-7724) or send an e-mail inquiry to ASKRPCI@roswellpark.org.